Obesity Drug
- All
- News
- Videos
-
Obesity: Why New Medications Are Not Miracle Cures
Recently, new drugs - analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have been added to the therapeutic arsenal, raising new hopes. However, they alone will not be enough to conquer obesity.
-
Opinion | The Rich Get Fit, And Poor Get 'Lectures' - That's India's Ozempic Problem
Ozempic has arrived in India - and so has the moral panic around it.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Could Dogs Get Their Version Of Ozempic? Scientists Test "Ozempup" For Pet Obesity
Biotech firm Vivani Medical has joined hands with Okava to work on a canine-friendly version of weight loss medications
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
Weight Loss Ad Sparks Controversy: "Don't Promote Obesity, It's A lifestyle Disease," Say Experts
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver and others.
-
Are Mounjaro Jabs Safe? Mass Rollout Of Weight Loss Drug To Start In UK
NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.
-
Mounjaro: Everything You Need To Know About This Medication
Read on as we discuss everything you need to know about this medication.
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
Biocon Launches Diabetes, Obesity Management Drug In UK
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
-
Obesity: Why New Medications Are Not Miracle Cures
Recently, new drugs - analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have been added to the therapeutic arsenal, raising new hopes. However, they alone will not be enough to conquer obesity.
-
Opinion | The Rich Get Fit, And Poor Get 'Lectures' - That's India's Ozempic Problem
Ozempic has arrived in India - and so has the moral panic around it.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Could Dogs Get Their Version Of Ozempic? Scientists Test "Ozempup" For Pet Obesity
Biotech firm Vivani Medical has joined hands with Okava to work on a canine-friendly version of weight loss medications
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
Weight Loss Ad Sparks Controversy: "Don't Promote Obesity, It's A lifestyle Disease," Say Experts
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver and others.
-
Are Mounjaro Jabs Safe? Mass Rollout Of Weight Loss Drug To Start In UK
NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.
-
Mounjaro: Everything You Need To Know About This Medication
Read on as we discuss everything you need to know about this medication.
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
Biocon Launches Diabetes, Obesity Management Drug In UK
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
